MSB 3.42% $1.21 mesoblast limited

Cell Therapy News/Articles, page-8333

  1. 3,956 Posts.
    lightbulb Created with Sketch. 1357
    https://cartherics.com/news/good-news-from-cartherics-the-companys-off-the-shelf-immune-therapy-for-ovarian-cancer-is-close-to-clinical-trials/
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.